{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:17:54Z","timestamp":1783498674460,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82073139"],"award-info":[{"award-number":["Grant No. 82073139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["Grant No. 2020J02054"],"award-info":[{"award-number":["Grant No. 2020J02054"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["Grant No.2021Y9058"],"award-info":[{"award-number":["Grant No.2021Y9058"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04688-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:24:55Z","timestamp":1770881095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer antigen 125 levels change rule after laparoscopic biopsy and its prognostic value for patients with unresectable pancreatic ductal adenocarcinoma: a retrospective preliminary exploratory study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yunjie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronggui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heguang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-7216","authenticated-orcid":false,"given":"Fengchun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"3","key":"4688_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4688_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, Hackert T, Golan T, Prager G, Haustermans K, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"issue":"9","key":"4688_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: A review. JAMA. 2021;326(9):851\u201362.","journal-title":"JAMA"},{"issue":"8","key":"4688_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"1","key":"4688_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/rg.2017160054","volume":"37","author":"AM Zaky","year":"2017","unstructured":"Zaky AM, Wolfgang CL, Weiss MJ, Javed AA, Fishman EK, Zaheer A. Tumor-Vessel relationships in pancreatic ductal adenocarcinoma at multidetector CT: different classification systems and their influence on treatment planning. Radiographics. 2017;37(1):93\u2013112.","journal-title":"Radiographics"},{"issue":"10","key":"4688_CR6","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1245\/s10434-011-1693-4","volume":"18","author":"DM Walters","year":"2011","unstructured":"Walters DM, Lapar DJ, de Lange EE, Sarti M, Stokes JB, Adams RB, Bauer TW. Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2011;18(10):2764\u201371.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4688_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jmri.27056","volume":"53","author":"M Alabousi","year":"2021","unstructured":"Alabousi M, McInnes MD, Salameh JP, Satkunasingham J, Kagoma YK, Ruo L, Meyers BM, Aziz T, van der Pol CB. MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: A comparative diagnostic test accuracy systematic review and Meta-Analysis. J Magn Reson Imaging. 2021;53(1):38\u201348.","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"4688_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ejso.2013.12.019","volume":"40","author":"E Beenen","year":"2014","unstructured":"Beenen E, van Roest MH, Sieders E, Peeters PM, Porte RJ, de Boer MT, de Jong KP. Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found. Eur J Surg Oncol. 2014;40(8):989\u201394.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4688_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ases.12138","volume":"8","author":"D Hashimoto","year":"2015","unstructured":"Hashimoto D, Chikamoto A, Sakata K, Nakagawa S, Hayashi H, Ohmuraya M, Hirota M, Yoshida N, Beppu T, Baba H. Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers. Asian J Endosc Surg. 2015;8(1):59\u201362.","journal-title":"Asian J Endosc Surg"},{"key":"4688_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12876-015-0270-x","volume":"15","author":"S Morris","year":"2015","unstructured":"Morris S, Gurusamy KS, Sheringham J, Davidson BR. Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer. BMC Gastroenterol. 2015;15:44.","journal-title":"BMC Gastroenterol"},{"issue":"22","key":"4688_CR11","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","volume":"34","author":"EP Balaban","year":"2016","unstructured":"Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, et al. Locally Advanced, unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(22):2654\u201368.","journal-title":"J Clin Oncol"},{"issue":"26","key":"4688_CR12","doi-asserted-by":"publisher","first-page":"109500","DOI":"10.3748\/wjg.v31.i26.109500","volume":"31","author":"S Ren","year":"2025","unstructured":"Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum Exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol. 2025;31(26):109500.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"4688_CR13","doi-asserted-by":"publisher","first-page":"109373","DOI":"10.4329\/wjr.v17.i8.109373","volume":"17","author":"S Ren","year":"2025","unstructured":"Ren S, Qin B, Daniels MJ, Zeng L, Tian Y, Wang ZQ. Developing and validating a computed tomography radiomics strategy to predict lymph node metastasis in pancreatic cancer. World J Radiol. 2025;17(8):109373.","journal-title":"World J Radiol"},{"issue":"5","key":"4688_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1515\/cclm-2017-0046","volume":"55","author":"FB Abreu","year":"2017","unstructured":"Abreu FB, Liu X, Tsongalis GJ. MiRNA analysis in pancreatic cancer: the Dartmouth experience. Clin Chem Lab Med. 2017;55(5):755\u201362.","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"4688_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00595-020-02121-4","volume":"51","author":"T Takadate","year":"2021","unstructured":"Takadate T, Morikawa T, Ishida M, Aoki S, Hata T, Iseki M, Miura T, Ariake K, Maeda S, Kawaguchi K, et al. Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases. Surg Today. 2021;51(5):686\u201394.","journal-title":"Surg Today"},{"issue":"7","key":"4688_CR16","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00423-021-02199-5","volume":"406","author":"X Lin","year":"2021","unstructured":"Lin X, Lin R, Lu F, Yang Y, Wang C, Fang H, Chen Y, Huang H. Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution. Langenbecks Arch Surg. 2021;406(7):2315\u201323.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"4688_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/XCS.0000000000000704","volume":"237","author":"H Gudmundsdottir","year":"2023","unstructured":"Gudmundsdottir H, Yonkus JA, Alva-Ruiz R, Kendrick ML, Smoot RL, Warner SG, Starlinger P, Thiels CA, Nagorney DM, Cleary SP, et al. Yield of staging laparoscopy for pancreatic cancer in the modern era: analysis of more than 1,000 consecutive patients. J Am Coll Surg. 2023;237(1):49\u201357.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"4688_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12957-022-02803-y","volume":"20","author":"MA Jambor","year":"2022","unstructured":"Jambor MA, Ashrafizadeh A, Nahm CB, Clarke SJ, Pavlakis N, Kneebone A, Hruby G, Gill AJ, Mittal A, Samra JS. The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients\u2019 survival. World J Surg Oncol. 2022;20(1):337.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4688_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","volume":"43","author":"W Luo","year":"2024","unstructured":"Luo W, Wen T, Qu X. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J Exp Clin Cancer Res. 2024;43(1):8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"4688_CR20","doi-asserted-by":"publisher","first-page":"25285","DOI":"10.1021\/acsami.3c00865","volume":"15","author":"K Guo","year":"2023","unstructured":"Guo K, Ren S, Zhang H, Cao Y, Zhao Y, Wang Y, Qiu W, Tian Y, Song L, Wang Z. Biomimetic gold nanorods modified with erythrocyte membranes for Imaging-Guided Photothermal\/Gene synergistic therapy. ACS Appl Mater Interfaces. 2023;15(21):25285\u201399.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4688_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","volume":"867","author":"S Scara","year":"2015","unstructured":"Scara S, Bottoni P, Scatena R. CA 19\u2009\u2013\u20099: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:247\u201360.","journal-title":"Adv Exp Med Biol"},{"key":"4688_CR22","doi-asserted-by":"crossref","unstructured":"Stemmler J, Stieber P, Szymala AM, Schalhorn A, Schermuly MM, Wilkowski R, Helmberger T, Lamerz R, Stoffregen C, Niebler K et al. Are serial CA 19\u2009\u2013\u20099 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie. 2003;6(5):462\u20137.","DOI":"10.1159\/000072980"},{"issue":"8","key":"4688_CR23","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/sj.bjc.6601263","volume":"89","author":"C Ziske","year":"2003","unstructured":"Ziske C, Schlie C, Gorschl\u00fcter M, Glasmacher A, Mey U, Strehl J, Sauerbruch T, Schmidt-Wolf IGH. Prognostic value of CA 19\u2009\u2013\u20099 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer. 2003;89(8):1413\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"4688_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.bjc.6602687","volume":"93","author":"AH Ko","year":"2005","unstructured":"Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA. Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer. 2005;93(2):195\u20139.","journal-title":"Br J Cancer"},{"issue":"4","key":"4688_CR25","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.06.1483","volume":"73","author":"WS Koom","year":"2009","unstructured":"Koom WS, Seong J, Kim YB, Pyun HO, Song SY. CA 19\u2009\u2013\u20099 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(4):1148\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4688_CR26","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1096\/fj.14-257352","volume":"28","author":"D Haridas","year":"2014","unstructured":"Haridas D, Ponnusamy MP, Chugh S, Lakshmanan I, Seshacharyulu P, Batra SK. MUC16: molecular analysis and its functional implications in benign and malignant conditions. FASEB J. 2014;28(10):4183\u201399.","journal-title":"FASEB J"},{"issue":"2","key":"4688_CR27","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188503.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"4688_CR28","doi-asserted-by":"publisher","first-page":"e26839","DOI":"10.1371\/journal.pone.0026839","volume":"6","author":"D Haridas","year":"2011","unstructured":"Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, et al. Pathobiological implications of MUC16 expression in pancreatic cancer. PLoS ONE. 2011;6(10):e26839.","journal-title":"PLoS ONE"},{"key":"4688_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","volume":"418","author":"K Fan","year":"2018","unstructured":"Fan K, Yang C, Fan Z, Huang Q, Zhang Y, Cheng H, Jin K, Lu Y, Wang Z, Luo G, et al. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. Cancer Lett. 2018;418:167\u201375.","journal-title":"Cancer Lett"},{"issue":"3\u20134","key":"4688_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.18632\/genesandcancer.104","volume":"7","author":"S Muniyan","year":"2016","unstructured":"Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes Cancer. 2016;7(3\u20134):110\u201324.","journal-title":"Genes Cancer"},{"issue":"8","key":"4688_CR31","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.18632\/oncotarget.3308","volume":"6","author":"S Das","year":"2015","unstructured":"Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget. 2015;6(8):5772\u201387.","journal-title":"Oncotarget"},{"issue":"22","key":"4688_CR32","doi-asserted-by":"publisher","first-page":"19118","DOI":"10.18632\/oncotarget.4078","volume":"6","author":"SK Shukla","year":"2015","unstructured":"Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, et al. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. 2015;6(22):19118\u201331.","journal-title":"Oncotarget"},{"issue":"12","key":"4688_CR33","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s11605-013-2389-9","volume":"17","author":"G Luo","year":"2013","unstructured":"Luo G, Xiao Z, Long J, Liu Z, Liu L, Liu C, Xu J, Ni Q, Yu X. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. J Gastrointest Surg. 2013;17(12):2092\u20138.","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"4688_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/jhbp.109","volume":"21","author":"K Okada","year":"2014","unstructured":"Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H. Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2014;21(9):648\u201353.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"4688_CR35","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s13304-023-01587-4","volume":"75","author":"N Napoli","year":"2023","unstructured":"Napoli N, Kauffmann EF, Ginesini M, Lami L, Lombardo C, Vistoli F, Campani D, Boggi U. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas. Updates Surg. 2023;75(6):1481\u201396.","journal-title":"Updates Surg"},{"issue":"5","key":"4688_CR36","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.18632\/oncotarget.6819","volume":"7","author":"L Liu","year":"2016","unstructured":"Liu L, Xu HX, Wang WQ, Wu CT, Xiang JF, Liu C, Long J, Xu J, Fu de L, Ni QX, et al. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget. 2016;7(5):5943\u201356.","journal-title":"Oncotarget"},{"issue":"1","key":"4688_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-023-11346-8","volume":"23","author":"X Luo","year":"2023","unstructured":"Luo X, Lin X, Lin R, Yang Y, Wang C, Fang H, Huang H, Lu F. The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer. BMC Cancer. 2023;23(1):832.","journal-title":"BMC Cancer"},{"issue":"2","key":"4688_CR38","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4688_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ags3.12295","volume":"4","author":"S Satoi","year":"2020","unstructured":"Satoi S, Yamamoto T, Yamaki S, Sakaguchi T, Sekimoto M. Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma. Annals Gastroenterological Surg. 2020;4(1):6\u201313.","journal-title":"Annals Gastroenterological Surg"},{"issue":"1","key":"4688_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13304-021-01089-1","volume":"74","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Liao S, You J, Wu H. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma following induction therapy: a systematic review of the published literature. Updates Surg. 2022;74(1):43\u201353.","journal-title":"Updates Surg"},{"issue":"8","key":"4688_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMc1107627","volume":"365","author":"V Vaccaro","year":"2011","unstructured":"Vaccaro V, Sperduti I, Milella M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;365(8):768\u20139. author reply 769.","journal-title":"N Engl J Med"},{"issue":"18","key":"4688_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691\u2013703.","journal-title":"N Engl J Med"},{"issue":"2","key":"4688_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/bjs.7305","volume":"98","author":"M Kanda","year":"2011","unstructured":"Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268\u201374.","journal-title":"Br J Surg"},{"issue":"18","key":"4688_CR44","doi-asserted-by":"publisher","first-page":"29925","DOI":"10.18632\/oncotarget.15557","volume":"8","author":"Y Chen","year":"2017","unstructured":"Chen Y, Shao Z, Chen W, Xie H, Wu Z, Qin G, Zhao N. A varying-coefficient Cox model for the effect of CA19-9 kinetics on overall survival in patients with advanced pancreatic cancer. Oncotarget. 2017;8(18):29925\u201334.","journal-title":"Oncotarget"},{"issue":"11","key":"4688_CR45","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.ejso.2017.07.010","volume":"43","author":"C Yang","year":"2017","unstructured":"Yang C, Cheng H, Luo G, Lu Y, Guo M, Jin K, Wang Z, Yu X, Liu C. The metastasis status and tumor burden-associated CA125 level combined with the CD4\/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system. Eur J Surg Oncol. 2017;43(11):2112\u20138.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4688_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jso.26735","volume":"125","author":"CA McIntyre","year":"2022","unstructured":"McIntyre CA, Cohen NA, Goldman DA, Gonen M, Sadot E, O\u2019Reilly EM, Varghese AM, Yu KH, Balachandran VP, Soares KC, et al. Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma. J Surg Oncol. 2022;125(3):425\u201336.","journal-title":"J Surg Oncol"},{"key":"4688_CR47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fgene.2019.00899","volume":"10","author":"P Waldmann","year":"2019","unstructured":"Waldmann P. On the use of the pearson correlation coefficient for model evaluation in Genome-Wide prediction. Front Genet. 2019;10:899.","journal-title":"Front Genet"},{"key":"4688_CR48","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/srep01870","volume":"3","author":"SH Chen","year":"2013","unstructured":"Chen SH, Hung WC, Wang P, Paul C, Konstantopoulos K. Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation. Sci Rep. 2013;3:1870.","journal-title":"Sci Rep"},{"issue":"3","key":"4688_CR49","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1096\/fj.11-195669","volume":"26","author":"SH Chen","year":"2012","unstructured":"Chen SH, Dallas MR, Balzer EM, Konstantopoulos K. Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J. 2012;26(3):1349\u201359.","journal-title":"FASEB J"},{"issue":"4","key":"4688_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/172460089801300403","volume":"13","author":"TJ O\u2019Brien","year":"1998","unstructured":"O\u2019Brien TJ, Tanimoto H, Konishi I, Gee M. More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int J Biol Markers. 1998;13(4):188\u201395.","journal-title":"Int J Biol Markers"},{"issue":"4","key":"4688_CR51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLE.0000000000000288","volume":"26","author":"I Bhatti","year":"2016","unstructured":"Bhatti I, Ojo D, Dennison AR, Rees Y, Elabassy M, Garcea G. Percutaneous pancreatic Biopsies-Still an effective method for histologic confirmation of malignancy. Surg Laparosc Endosc Percutan Tech. 2016;26(4):334\u20137.","journal-title":"Surg Laparosc Endosc Percutan Tech"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04688-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:04:18Z","timestamp":1783497858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04688-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04688-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original publication was updated to amend the Funding declaration.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is being conducted according to the guidelines of the Declaration of Helsinki and was approved by the ethics committee of Fujian Medical University Union Hospital. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}